ch.linkedin.com/company/araris-biotech
Preview meta tags from the ch.linkedin.com website.
Linked Hostnames
13- 63 links towww.linkedin.com
- 25 links toch.linkedin.com
- 5 links tolnkd.in
- 4 links tode.linkedin.com
- 4 links towww.crunchbase.com
- 2 links tofr.linkedin.com
- 1 link toabout.linkedin.com
- 1 link toaiscongress.com
Thumbnail
Search Engine Appearance
Araris Biotech AG | LinkedIn
Araris Biotech AG | 8.195 Follower:innen auf LinkedIn. Building tomorrow's antibody-drug conjugates (ADCs) | Araris Biotech AG is pioneering a novel linker technology for antibody-drug conjugates (ADCs.) Our linker platform enables the attachment of any payload to ‘off the shelf’ antibodies without the need of prior antibody engineering.
Bing
Araris Biotech AG | LinkedIn
Araris Biotech AG | 8.195 Follower:innen auf LinkedIn. Building tomorrow's antibody-drug conjugates (ADCs) | Araris Biotech AG is pioneering a novel linker technology for antibody-drug conjugates (ADCs.) Our linker platform enables the attachment of any payload to ‘off the shelf’ antibodies without the need of prior antibody engineering.
DuckDuckGo
Araris Biotech AG | LinkedIn
Araris Biotech AG | 8.195 Follower:innen auf LinkedIn. Building tomorrow's antibody-drug conjugates (ADCs) | Araris Biotech AG is pioneering a novel linker technology for antibody-drug conjugates (ADCs.) Our linker platform enables the attachment of any payload to ‘off the shelf’ antibodies without the need of prior antibody engineering.
General Meta Tags
15- titleAraris Biotech AG | LinkedIn
- pageKeyd_org_guest_company_overview
- robotsmax-image-preview:large, noarchive
- bingbotmax-image-preview:large, archive
- linkedin:pageTagnoncanonical_subdomain=control
Open Graph Meta Tags
5- og:titleAraris Biotech AG | LinkedIn
- og:descriptionAraris Biotech AG | 8.195 Follower:innen auf LinkedIn. Building tomorrow's antibody-drug conjugates (ADCs) | Araris Biotech AG is pioneering a novel linker technology for antibody-drug conjugates (ADCs.) Our linker platform enables the attachment of any payload to ‘off the shelf’ antibodies without the need of prior antibody engineering.
- og:imagehttps://media.licdn.com/dms/image/v2/D4D0BAQE-EUP7pefZVA/company-logo_200_200/B4DZlWhmvEJcAM-/0/1758093274573/araris_biotech_logo?e=2147483647&v=beta&t=ImQhvRE-Oa2c9t-9z8Aj4VhjeL-kf7CDm0jDEGj-WMc
- og:typearticle
- og:urlhttps://ch.linkedin.com/company/araris-biotech
Twitter Meta Tags
5- twitter:cardsummary
- twitter:site@linkedin
- twitter:titleAraris Biotech AG | LinkedIn
- twitter:descriptionAraris Biotech AG | 8.195 Follower:innen auf LinkedIn. Building tomorrow's antibody-drug conjugates (ADCs) | Araris Biotech AG is pioneering a novel linker technology for antibody-drug conjugates (ADCs.) Our linker platform enables the attachment of any payload to ‘off the shelf’ antibodies without the need of prior antibody engineering.
- twitter:imagehttps://media.licdn.com/dms/image/v2/D4D0BAQE-EUP7pefZVA/company-logo_200_200/B4DZlWhmvEJcAM-/0/1758093274573/araris_biotech_logo?e=2147483647&v=beta&t=ImQhvRE-Oa2c9t-9z8Aj4VhjeL-kf7CDm0jDEGj-WMc
Link Tags
3- canonicalhttps://ch.linkedin.com/company/araris-biotech
- iconhttps://static.licdn.com/aero-v1/sc/h/al2o9zrvru7aqj8e1x2rzsrca
- stylesheethttps://static.licdn.com/aero-v1/sc/h/cirpmsude3riayhz1h8sc0nzn
Website Locales
2de-CH
https://ch.linkedin.com/company/araris-biotechx-default
https://ch.linkedin.com/company/araris-biotech
Emails
1- [email protected]?trk=organization_guest_main-feed-card-text
Links
110- http://Flot.Bio?trk=organization_guest_main-feed-card-text
- https://about.linkedin.com?trk=d_org_guest_company_overview_footer-about
- https://aiscongress.com/?trk=organization_guest_main-feed-card-text
- https://brand.linkedin.com/policies?trk=d_org_guest_company_overview_footer-brand-policy
- https://ch.linkedin.com/?trk=organization_guest_nav-header-logo